Analyst Price Target is $40.57
▲ +29.09% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for SI-BONE in the last 3 months. The average price target is $40.57, with a high forecast of $43.00 and a low forecast of $35.00. The average price target represents a 29.09% upside from the last price of $31.43.
Current Consensus is
The current consensus among 6 polled investment analysts is to buy stock in SI-BONE.
SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally. The company offers iFuse, a minimally invasive surgical implant system, which is intended to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.